nodes	percent_of_prediction	percent_of_DWPC	metapath
Prasugrel—ALB—melanoma	0.386	1	CbGaD
Prasugrel—ALB—Vemurafenib—melanoma	0.173	0.502	CbGbCtD
Prasugrel—CYP3A4—Temozolomide—melanoma	0.0988	0.287	CbGbCtD
Prasugrel—CYP3A4—Vemurafenib—melanoma	0.0541	0.157	CbGbCtD
Prasugrel—CYP3A4—Docetaxel—melanoma	0.0186	0.054	CbGbCtD
Prasugrel—Non-cardiac chest pain—Docetaxel—melanoma	0.00683	0.0524	CcSEcCtD
Prasugrel—Retinal haemorrhage—Carmustine—melanoma	0.00565	0.0434	CcSEcCtD
Prasugrel—Haemorrhage intracranial—Temozolomide—melanoma	0.00434	0.0333	CcSEcCtD
Prasugrel—Neoplasm malignant—Vemurafenib—melanoma	0.00408	0.0313	CcSEcCtD
Prasugrel—Neoplasm—Vemurafenib—melanoma	0.00315	0.0242	CcSEcCtD
Prasugrel—Pericardial effusion—Docetaxel—melanoma	0.00289	0.0222	CcSEcCtD
Prasugrel—Atrial fibrillation—Vemurafenib—melanoma	0.00267	0.0205	CcSEcCtD
Prasugrel—Pain in extremity—Vemurafenib—melanoma	0.00253	0.0194	CcSEcCtD
Prasugrel—Oedema peripheral—Vemurafenib—melanoma	0.00172	0.0132	CcSEcCtD
Prasugrel—Neoplasm—Carmustine—melanoma	0.00167	0.0128	CcSEcCtD
Prasugrel—Eye disorder—Vemurafenib—melanoma	0.00163	0.0126	CcSEcCtD
Prasugrel—Neoplasm—Temozolomide—melanoma	0.00161	0.0124	CcSEcCtD
Prasugrel—Angiopathy—Vemurafenib—melanoma	0.00159	0.0122	CcSEcCtD
Prasugrel—Mediastinal disorder—Vemurafenib—melanoma	0.00158	0.0121	CcSEcCtD
Prasugrel—Cerebrovascular accident—Bleomycin—melanoma	0.00156	0.012	CcSEcCtD
Prasugrel—Back pain—Vemurafenib—melanoma	0.00147	0.0113	CcSEcCtD
Prasugrel—Gastrointestinal haemorrhage—Carmustine—melanoma	0.00134	0.0103	CcSEcCtD
Prasugrel—Cough—Vemurafenib—melanoma	0.00133	0.0102	CcSEcCtD
Prasugrel—Unspecified disorder of skin and subcutaneous tissue—Vemurafenib—melanoma	0.00129	0.00989	CcSEcCtD
Prasugrel—Anaphylactic shock—Vemurafenib—melanoma	0.00124	0.00955	CcSEcCtD
Prasugrel—Skin disorder—Vemurafenib—melanoma	0.00121	0.00928	CcSEcCtD
Prasugrel—Hypotension—Vemurafenib—melanoma	0.00116	0.00892	CcSEcCtD
Prasugrel—Haematuria—Bleomycin—melanoma	0.00113	0.00865	CcSEcCtD
Prasugrel—Gastrointestinal disorder—Vemurafenib—melanoma	0.00107	0.00824	CcSEcCtD
Prasugrel—Fatigue—Vemurafenib—melanoma	0.00107	0.00823	CcSEcCtD
Prasugrel—Neoplasm—Docetaxel—melanoma	0.00107	0.00822	CcSEcCtD
Prasugrel—Haemoglobin—Bleomycin—melanoma	0.00107	0.00818	CcSEcCtD
Prasugrel—Haemorrhage—Bleomycin—melanoma	0.00106	0.00814	CcSEcCtD
Prasugrel—Body temperature increased—Vemurafenib—melanoma	0.000982	0.00755	CcSEcCtD
Prasugrel—Haemoglobin—Carmustine—melanoma	0.00093	0.00714	CcSEcCtD
Prasugrel—Haemorrhage—Carmustine—melanoma	0.000925	0.00711	CcSEcCtD
Prasugrel—Hypersensitivity—Vemurafenib—melanoma	0.000916	0.00704	CcSEcCtD
Prasugrel—Oedema peripheral—Carmustine—melanoma	0.000911	0.007	CcSEcCtD
Prasugrel—Atrial fibrillation—Docetaxel—melanoma	0.000907	0.00697	CcSEcCtD
Prasugrel—Haemoglobin—Temozolomide—melanoma	0.000898	0.0069	CcSEcCtD
Prasugrel—Haemorrhage—Temozolomide—melanoma	0.000894	0.00687	CcSEcCtD
Prasugrel—Asthenia—Vemurafenib—melanoma	0.000892	0.00685	CcSEcCtD
Prasugrel—Urinary tract disorder—Temozolomide—melanoma	0.000883	0.00678	CcSEcCtD
Prasugrel—Oedema peripheral—Temozolomide—melanoma	0.000881	0.00677	CcSEcCtD
Prasugrel—Urethral disorder—Temozolomide—melanoma	0.000876	0.00673	CcSEcCtD
Prasugrel—Eye disorder—Carmustine—melanoma	0.000864	0.00664	CcSEcCtD
Prasugrel—Gastrointestinal haemorrhage—Docetaxel—melanoma	0.000859	0.0066	CcSEcCtD
Prasugrel—Pain in extremity—Docetaxel—melanoma	0.000859	0.0066	CcSEcCtD
Prasugrel—Anaemia—Bleomycin—melanoma	0.000853	0.00655	CcSEcCtD
Prasugrel—Diarrhoea—Vemurafenib—melanoma	0.00085	0.00653	CcSEcCtD
Prasugrel—Eye disorder—Temozolomide—melanoma	0.000835	0.00642	CcSEcCtD
Prasugrel—Leukopenia—Bleomycin—melanoma	0.000826	0.00635	CcSEcCtD
Prasugrel—Dizziness—Vemurafenib—melanoma	0.000822	0.00631	CcSEcCtD
Prasugrel—Angiopathy—Temozolomide—melanoma	0.000811	0.00623	CcSEcCtD
Prasugrel—Immune system disorder—Temozolomide—melanoma	0.000807	0.0062	CcSEcCtD
Prasugrel—Clopidogrel—ABCB1—melanoma	0.000807	1	CrCbGaD
Prasugrel—Mediastinal disorder—Temozolomide—melanoma	0.000806	0.00619	CcSEcCtD
Prasugrel—Cough—Bleomycin—melanoma	0.000805	0.00619	CcSEcCtD
Prasugrel—Anaemia—Dactinomycin—melanoma	0.000795	0.00611	CcSEcCtD
Prasugrel—Rash—Vemurafenib—melanoma	0.000784	0.00602	CcSEcCtD
Prasugrel—Dermatitis—Vemurafenib—melanoma	0.000783	0.00602	CcSEcCtD
Prasugrel—Back pain—Carmustine—melanoma	0.000779	0.00599	CcSEcCtD
Prasugrel—Headache—Vemurafenib—melanoma	0.000778	0.00598	CcSEcCtD
Prasugrel—Leukopenia—Dactinomycin—melanoma	0.00077	0.00592	CcSEcCtD
Prasugrel—Anaphylactic shock—Bleomycin—melanoma	0.000753	0.00579	CcSEcCtD
Prasugrel—Back pain—Temozolomide—melanoma	0.000753	0.00578	CcSEcCtD
Prasugrel—Anaemia—Carmustine—melanoma	0.000744	0.00572	CcSEcCtD
Prasugrel—Nausea—Vemurafenib—melanoma	0.000738	0.00567	CcSEcCtD
Prasugrel—Thrombocytopenia—Bleomycin—melanoma	0.000737	0.00566	CcSEcCtD
Prasugrel—Leukopenia—Carmustine—melanoma	0.000721	0.00554	CcSEcCtD
Prasugrel—Anaemia—Temozolomide—melanoma	0.000719	0.00553	CcSEcCtD
Prasugrel—Angioedema—Temozolomide—melanoma	0.000711	0.00546	CcSEcCtD
Prasugrel—Hypotension—Bleomycin—melanoma	0.000704	0.00541	CcSEcCtD
Prasugrel—Leukopenia—Temozolomide—melanoma	0.000697	0.00535	CcSEcCtD
Prasugrel—Hypertension—Carmustine—melanoma	0.000695	0.00534	CcSEcCtD
Prasugrel—Thrombocytopenia—Dactinomycin—melanoma	0.000687	0.00528	CcSEcCtD
Prasugrel—Cough—Temozolomide—melanoma	0.000679	0.00522	CcSEcCtD
Prasugrel—Hypertension—Temozolomide—melanoma	0.000672	0.00516	CcSEcCtD
Prasugrel—Dyspnoea—Bleomycin—melanoma	0.000671	0.00516	CcSEcCtD
Prasugrel—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—melanoma	0.000658	0.00506	CcSEcCtD
Prasugrel—Thrombocytopenia—Carmustine—melanoma	0.000643	0.00494	CcSEcCtD
Prasugrel—Anaphylactic shock—Temozolomide—melanoma	0.000635	0.00488	CcSEcCtD
Prasugrel—Epistaxis—Docetaxel—melanoma	0.000625	0.0048	CcSEcCtD
Prasugrel—Thrombocytopenia—Temozolomide—melanoma	0.000622	0.00478	CcSEcCtD
Prasugrel—Skin disorder—Temozolomide—melanoma	0.000617	0.00474	CcSEcCtD
Prasugrel—Hypotension—Carmustine—melanoma	0.000614	0.00472	CcSEcCtD
Prasugrel—Fatigue—Dactinomycin—melanoma	0.000605	0.00465	CcSEcCtD
Prasugrel—Haemoglobin—Docetaxel—melanoma	0.000597	0.00459	CcSEcCtD
Prasugrel—Body temperature increased—Bleomycin—melanoma	0.000595	0.00457	CcSEcCtD
Prasugrel—Haemorrhage—Docetaxel—melanoma	0.000594	0.00457	CcSEcCtD
Prasugrel—Urinary tract disorder—Docetaxel—melanoma	0.000587	0.00451	CcSEcCtD
Prasugrel—Dyspnoea—Carmustine—melanoma	0.000586	0.0045	CcSEcCtD
Prasugrel—Oedema peripheral—Docetaxel—melanoma	0.000586	0.0045	CcSEcCtD
Prasugrel—Urethral disorder—Docetaxel—melanoma	0.000583	0.00448	CcSEcCtD
Prasugrel—Gastrointestinal disorder—Carmustine—melanoma	0.000567	0.00436	CcSEcCtD
Prasugrel—Dyspnoea—Temozolomide—melanoma	0.000566	0.00435	CcSEcCtD
Prasugrel—Eye disorder—Docetaxel—melanoma	0.000556	0.00427	CcSEcCtD
Prasugrel—Body temperature increased—Dactinomycin—melanoma	0.000555	0.00427	CcSEcCtD
Prasugrel—Hypersensitivity—Bleomycin—melanoma	0.000555	0.00426	CcSEcCtD
Prasugrel—Gastrointestinal disorder—Temozolomide—melanoma	0.000548	0.00421	CcSEcCtD
Prasugrel—Fatigue—Temozolomide—melanoma	0.000548	0.00421	CcSEcCtD
Prasugrel—Asthenia—Bleomycin—melanoma	0.00054	0.00415	CcSEcCtD
Prasugrel—Angiopathy—Docetaxel—melanoma	0.000539	0.00414	CcSEcCtD
Prasugrel—Immune system disorder—Docetaxel—melanoma	0.000537	0.00413	CcSEcCtD
Prasugrel—Mediastinal disorder—Docetaxel—melanoma	0.000536	0.00412	CcSEcCtD
Prasugrel—Body temperature increased—Carmustine—melanoma	0.00052	0.00399	CcSEcCtD
Prasugrel—Hypersensitivity—Dactinomycin—melanoma	0.000517	0.00398	CcSEcCtD
Prasugrel—Asthenia—Dactinomycin—melanoma	0.000504	0.00387	CcSEcCtD
Prasugrel—Body temperature increased—Temozolomide—melanoma	0.000502	0.00386	CcSEcCtD
Prasugrel—Back pain—Docetaxel—melanoma	0.000501	0.00385	CcSEcCtD
Prasugrel—Hypersensitivity—Carmustine—melanoma	0.000484	0.00372	CcSEcCtD
Prasugrel—Diarrhoea—Dactinomycin—melanoma	0.00048	0.00369	CcSEcCtD
Prasugrel—Anaemia—Docetaxel—melanoma	0.000478	0.00368	CcSEcCtD
Prasugrel—Rash—Bleomycin—melanoma	0.000475	0.00365	CcSEcCtD
Prasugrel—Dermatitis—Bleomycin—melanoma	0.000474	0.00364	CcSEcCtD
Prasugrel—Asthenia—Carmustine—melanoma	0.000472	0.00362	CcSEcCtD
Prasugrel—Hypersensitivity—Temozolomide—melanoma	0.000468	0.0036	CcSEcCtD
Prasugrel—Leukopenia—Docetaxel—melanoma	0.000463	0.00356	CcSEcCtD
Prasugrel—Asthenia—Temozolomide—melanoma	0.000456	0.0035	CcSEcCtD
Prasugrel—Cough—Docetaxel—melanoma	0.000452	0.00347	CcSEcCtD
Prasugrel—Diarrhoea—Carmustine—melanoma	0.00045	0.00346	CcSEcCtD
Prasugrel—Nausea—Bleomycin—melanoma	0.000447	0.00344	CcSEcCtD
Prasugrel—Hypertension—Docetaxel—melanoma	0.000447	0.00343	CcSEcCtD
Prasugrel—Rash—Dactinomycin—melanoma	0.000443	0.0034	CcSEcCtD
Prasugrel—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—melanoma	0.000438	0.00336	CcSEcCtD
Prasugrel—Dizziness—Carmustine—melanoma	0.000435	0.00334	CcSEcCtD
Prasugrel—Diarrhoea—Temozolomide—melanoma	0.000435	0.00334	CcSEcCtD
Prasugrel—Anaphylactic shock—Docetaxel—melanoma	0.000422	0.00325	CcSEcCtD
Prasugrel—Dizziness—Temozolomide—melanoma	0.00042	0.00323	CcSEcCtD
Prasugrel—Nausea—Dactinomycin—melanoma	0.000417	0.0032	CcSEcCtD
Prasugrel—Rash—Carmustine—melanoma	0.000414	0.00318	CcSEcCtD
Prasugrel—Dermatitis—Carmustine—melanoma	0.000414	0.00318	CcSEcCtD
Prasugrel—Thrombocytopenia—Docetaxel—melanoma	0.000414	0.00318	CcSEcCtD
Prasugrel—Headache—Carmustine—melanoma	0.000412	0.00316	CcSEcCtD
Prasugrel—Skin disorder—Docetaxel—melanoma	0.00041	0.00315	CcSEcCtD
Prasugrel—Rash—Temozolomide—melanoma	0.0004	0.00308	CcSEcCtD
Prasugrel—Dermatitis—Temozolomide—melanoma	0.0004	0.00307	CcSEcCtD
Prasugrel—Headache—Temozolomide—melanoma	0.000398	0.00306	CcSEcCtD
Prasugrel—Hypotension—Docetaxel—melanoma	0.000395	0.00303	CcSEcCtD
Prasugrel—Nausea—Carmustine—melanoma	0.00039	0.003	CcSEcCtD
Prasugrel—Nausea—Temozolomide—melanoma	0.000377	0.0029	CcSEcCtD
Prasugrel—Dyspnoea—Docetaxel—melanoma	0.000377	0.00289	CcSEcCtD
Prasugrel—Gastrointestinal disorder—Docetaxel—melanoma	0.000365	0.0028	CcSEcCtD
Prasugrel—Fatigue—Docetaxel—melanoma	0.000364	0.0028	CcSEcCtD
Prasugrel—Body temperature increased—Docetaxel—melanoma	0.000334	0.00257	CcSEcCtD
Prasugrel—Hypersensitivity—Docetaxel—melanoma	0.000311	0.00239	CcSEcCtD
Prasugrel—Asthenia—Docetaxel—melanoma	0.000303	0.00233	CcSEcCtD
Prasugrel—Diarrhoea—Docetaxel—melanoma	0.000289	0.00222	CcSEcCtD
Prasugrel—Dizziness—Docetaxel—melanoma	0.000279	0.00215	CcSEcCtD
Prasugrel—Rash—Docetaxel—melanoma	0.000266	0.00205	CcSEcCtD
Prasugrel—Dermatitis—Docetaxel—melanoma	0.000266	0.00204	CcSEcCtD
Prasugrel—Headache—Docetaxel—melanoma	0.000265	0.00203	CcSEcCtD
Prasugrel—Nausea—Docetaxel—melanoma	0.000251	0.00193	CcSEcCtD
Prasugrel—ALB—Metabolism—PHGDH—melanoma	3.55e-05	0.000255	CbGpPWpGaD
Prasugrel—ALB—Metabolism—LUM—melanoma	3.55e-05	0.000255	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—NOTCH1—melanoma	3.54e-05	0.000255	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism of lipids and lipoproteins—FASN—melanoma	3.5e-05	0.000251	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism of lipids and lipoproteins—CYP1B1—melanoma	3.49e-05	0.000251	CbGpPWpGaD
Prasugrel—ALB—Metabolism—HPSE—melanoma	3.48e-05	0.00025	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—CD80—melanoma	3.47e-05	0.000249	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—PIK3CG—melanoma	3.47e-05	0.000249	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—APC—melanoma	3.47e-05	0.000249	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—KIT—melanoma	3.47e-05	0.000249	CbGpPWpGaD
Prasugrel—P2RY12—Signaling by GPCR—NRAS—melanoma	3.47e-05	0.000249	CbGpPWpGaD
Prasugrel—ALB—Platelet activation, signaling and aggregation—IL2—melanoma	3.46e-05	0.000249	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—EGF—melanoma	3.43e-05	0.000246	CbGpPWpGaD
Prasugrel—ALB—Hemostasis—HGF—melanoma	3.42e-05	0.000245	CbGpPWpGaD
Prasugrel—ALB—Metabolism—CUBN—melanoma	3.42e-05	0.000245	CbGpPWpGaD
Prasugrel—ALB—Hemostasis—CSF2—melanoma	3.38e-05	0.000243	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—SLC6A11—melanoma	3.35e-05	0.000241	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—PIP4K2A—melanoma	3.35e-05	0.000241	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—UGT2B10—melanoma	3.34e-05	0.00024	CbGpPWpGaD
Prasugrel—P2RY12—Signaling by GPCR—MAPK3—melanoma	3.32e-05	0.000238	CbGpPWpGaD
Prasugrel—ALB—Metabolism—SDHD—melanoma	3.3e-05	0.000237	CbGpPWpGaD
Prasugrel—ALB—Metabolism—BSG—melanoma	3.3e-05	0.000237	CbGpPWpGaD
Prasugrel—ALB—Metabolism—CSPG4—melanoma	3.3e-05	0.000237	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—MTAP—melanoma	3.26e-05	0.000234	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—BRAF—melanoma	3.26e-05	0.000234	CbGpPWpGaD
Prasugrel—ALB—Hemostasis—ITGB3—melanoma	3.24e-05	0.000233	CbGpPWpGaD
Prasugrel—ALB—Hemostasis—PRKCA—melanoma	3.24e-05	0.000233	CbGpPWpGaD
Prasugrel—CYP2B6—Metabolism—PLA2G6—melanoma	3.23e-05	0.000232	CbGpPWpGaD
Prasugrel—ALB—Metabolism—GPAM—melanoma	3.2e-05	0.000229	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—PHGDH—melanoma	3.19e-05	0.000229	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—LUM—melanoma	3.19e-05	0.000229	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism of lipids and lipoproteins—CYP1B1—melanoma	3.19e-05	0.000229	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—IGF1—melanoma	3.17e-05	0.000228	CbGpPWpGaD
Prasugrel—P2RY12—Signaling by GPCR—MAPK1—melanoma	3.16e-05	0.000227	CbGpPWpGaD
Prasugrel—P2RY12—Signaling by GPCR—EGFR—melanoma	3.16e-05	0.000227	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—HPSE—melanoma	3.12e-05	0.000224	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—HS3ST5—melanoma	3.1e-05	0.000223	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—MAP2K1—melanoma	3.07e-05	0.00022	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—CUBN—melanoma	3.07e-05	0.00022	CbGpPWpGaD
Prasugrel—ALB—Transmembrane transport of small molecules—ABCB1—melanoma	3.05e-05	0.000219	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—PIK3CD—melanoma	3.05e-05	0.000219	CbGpPWpGaD
Prasugrel—P2RY12—GPCR downstream signaling—PIK3CA—melanoma	3.02e-05	0.000217	CbGpPWpGaD
Prasugrel—ALB—Hemostasis—RAC1—melanoma	3e-05	0.000216	CbGpPWpGaD
Prasugrel—P2RY12—Signaling by GPCR—KRAS—melanoma	2.98e-05	0.000214	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—CSPG4—melanoma	2.96e-05	0.000213	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—SDHD—melanoma	2.96e-05	0.000213	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—BSG—melanoma	2.96e-05	0.000213	CbGpPWpGaD
Prasugrel—ALB—Platelet activation, signaling and aggregation—VEGFA—melanoma	2.94e-05	0.000211	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—FGF2—melanoma	2.92e-05	0.00021	CbGpPWpGaD
Prasugrel—ALB—Hemostasis—MMP1—melanoma	2.91e-05	0.000209	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—LUM—melanoma	2.91e-05	0.000209	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—PHGDH—melanoma	2.91e-05	0.000209	CbGpPWpGaD
Prasugrel—CYP2B6—Metabolism—VCAN—melanoma	2.9e-05	0.000208	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—GPAM—melanoma	2.87e-05	0.000206	CbGpPWpGaD
Prasugrel—ALB—Hemostasis—CDK2—melanoma	2.85e-05	0.000205	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—HPSE—melanoma	2.85e-05	0.000205	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—CUBN—melanoma	2.8e-05	0.000201	CbGpPWpGaD
Prasugrel—ALB—Platelet activation, signaling and aggregation—MAPK3—melanoma	2.79e-05	0.0002	CbGpPWpGaD
Prasugrel—P2RY12—Signaling by GPCR—PIK3CA—melanoma	2.74e-05	0.000197	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—MDM2—melanoma	2.73e-05	0.000196	CbGpPWpGaD
Prasugrel—ALB—Metabolism—PLA2G6—melanoma	2.72e-05	0.000195	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—SDHD—melanoma	2.7e-05	0.000194	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—BSG—melanoma	2.7e-05	0.000194	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—CSPG4—melanoma	2.7e-05	0.000194	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—ERBB2—melanoma	2.69e-05	0.000193	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—PIK3CB—melanoma	2.66e-05	0.000191	CbGpPWpGaD
Prasugrel—ALB—Hemostasis—FN1—melanoma	2.65e-05	0.00019	CbGpPWpGaD
Prasugrel—ALB—Platelet activation, signaling and aggregation—MAPK1—melanoma	2.65e-05	0.00019	CbGpPWpGaD
Prasugrel—ALB—Hemostasis—NOS2—melanoma	2.62e-05	0.000188	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—GPAM—melanoma	2.62e-05	0.000188	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—CXCL8—melanoma	2.55e-05	0.000183	CbGpPWpGaD
Prasugrel—ALB—Hemostasis—PIK3CG—melanoma	2.54e-05	0.000182	CbGpPWpGaD
Prasugrel—P2RY12—Signaling by GPCR—HRAS—melanoma	2.54e-05	0.000182	CbGpPWpGaD
Prasugrel—ALB—Hemostasis—EGF—melanoma	2.51e-05	0.00018	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—CDKN1B—melanoma	2.49e-05	0.000179	CbGpPWpGaD
Prasugrel—P2RY12—GPCR downstream signaling—AKT1—melanoma	2.47e-05	0.000177	CbGpPWpGaD
Prasugrel—CYP2B6—Metabolism—CYP17A1—melanoma	2.45e-05	0.000176	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—CASP3—melanoma	2.44e-05	0.000175	CbGpPWpGaD
Prasugrel—ALB—Metabolism—VCAN—melanoma	2.44e-05	0.000175	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—PLA2G6—melanoma	2.44e-05	0.000175	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—IL2—melanoma	2.44e-05	0.000175	CbGpPWpGaD
Prasugrel—P2RY12—Signaling by GPCR—IL6—melanoma	2.43e-05	0.000174	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—CCND1—melanoma	2.38e-05	0.000171	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—CTNNB1—melanoma	2.35e-05	0.000169	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—PLCB4—melanoma	2.35e-05	0.000169	CbGpPWpGaD
Prasugrel—ALB—Hemostasis—IGF1—melanoma	2.32e-05	0.000167	CbGpPWpGaD
Prasugrel—ALB—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	2.31e-05	0.000166	CbGpPWpGaD
Prasugrel—CYP2B6—Metabolism—GNA11—melanoma	2.31e-05	0.000166	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—MMP9—melanoma	2.31e-05	0.000166	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—CDKN1A—melanoma	2.3e-05	0.000165	CbGpPWpGaD
Prasugrel—ALB—Platelet activation, signaling and aggregation—PIK3CA—melanoma	2.3e-05	0.000165	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—PTEN—melanoma	2.3e-05	0.000165	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—NFKB1—melanoma	2.28e-05	0.000164	CbGpPWpGaD
Prasugrel—CYP2B6—Metabolism—FASN—melanoma	2.26e-05	0.000162	CbGpPWpGaD
Prasugrel—P2RY12—Signaling by GPCR—AKT1—melanoma	2.24e-05	0.000161	CbGpPWpGaD
Prasugrel—ALB—Hemostasis—PIK3CD—melanoma	2.23e-05	0.00016	CbGpPWpGaD
Prasugrel—ALB—Metabolism of lipids and lipoproteins—PPARG—melanoma	2.23e-05	0.00016	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—PLA2G6—melanoma	2.22e-05	0.00016	CbGpPWpGaD
Prasugrel—CYP2B6—Metabolism—SLC5A5—melanoma	2.22e-05	0.00016	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—SLC6A11—melanoma	2.21e-05	0.000159	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—PIP4K2A—melanoma	2.21e-05	0.000159	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—VCAN—melanoma	2.19e-05	0.000157	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—MTAP—melanoma	2.15e-05	0.000154	CbGpPWpGaD
Prasugrel—CYP2B6—Metabolism—GNAQ—melanoma	2.15e-05	0.000154	CbGpPWpGaD
Prasugrel—CYP2B6—Metabolism—CD44—melanoma	2.15e-05	0.000154	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	2.07e-05	0.000149	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—VEGFA—melanoma	2.07e-05	0.000149	CbGpPWpGaD
Prasugrel—ALB—Metabolism—CYP17A1—melanoma	2.06e-05	0.000148	CbGpPWpGaD
Prasugrel—CYP2B6—Metabolism—CYP1B1—melanoma	2.06e-05	0.000148	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—STAT3—melanoma	2.05e-05	0.000147	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—NRAS—melanoma	2.05e-05	0.000147	CbGpPWpGaD
Prasugrel—ALB—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	2.03e-05	0.000146	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—melanoma	2e-05	0.000144	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—VCAN—melanoma	2e-05	0.000143	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—MAPK3—melanoma	1.96e-05	0.000141	CbGpPWpGaD
Prasugrel—ALB—Metabolism—GNA11—melanoma	1.94e-05	0.00014	CbGpPWpGaD
Prasugrel—ALB—Hemostasis—PIK3CB—melanoma	1.94e-05	0.00014	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—LUM—melanoma	1.92e-05	0.000138	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—PHGDH—melanoma	1.92e-05	0.000138	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—MYC—melanoma	1.91e-05	0.000137	CbGpPWpGaD
Prasugrel—ALB—Metabolism—FASN—melanoma	1.9e-05	0.000137	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	1.89e-05	0.000136	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—HPSE—melanoma	1.88e-05	0.000135	CbGpPWpGaD
Prasugrel—ALB—Platelet activation, signaling and aggregation—AKT1—melanoma	1.88e-05	0.000135	CbGpPWpGaD
Prasugrel—ALB—Metabolism—SLC5A5—melanoma	1.87e-05	0.000134	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—MAPK1—melanoma	1.87e-05	0.000134	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—EGFR—melanoma	1.87e-05	0.000134	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—CYP17A1—melanoma	1.85e-05	0.000133	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—CUBN—melanoma	1.84e-05	0.000132	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—melanoma	1.83e-05	0.000131	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	1.82e-05	0.000131	CbGpPWpGaD
Prasugrel—ALB—Metabolism—GNAQ—melanoma	1.81e-05	0.00013	CbGpPWpGaD
Prasugrel—ALB—Metabolism—CD44—melanoma	1.81e-05	0.00013	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism of lipids and lipoproteins—ALB—melanoma	1.8e-05	0.000129	CbGpPWpGaD
Prasugrel—ALB—Hemostasis—IL2—melanoma	1.79e-05	0.000128	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—SDHD—melanoma	1.78e-05	0.000128	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—CSPG4—melanoma	1.78e-05	0.000128	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—BSG—melanoma	1.78e-05	0.000128	CbGpPWpGaD
Prasugrel—ALB—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	1.77e-05	0.000127	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—KRAS—melanoma	1.76e-05	0.000127	CbGpPWpGaD
Prasugrel—ALB—Metabolism of lipids and lipoproteins—PTGS2—melanoma	1.75e-05	0.000126	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—GNA11—melanoma	1.75e-05	0.000125	CbGpPWpGaD
Prasugrel—ALB—Metabolism—CYP1B1—melanoma	1.73e-05	0.000124	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—GPAM—melanoma	1.73e-05	0.000124	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—FASN—melanoma	1.71e-05	0.000123	CbGpPWpGaD
Prasugrel—CYP2B6—Metabolism—ABCB1—melanoma	1.7e-05	0.000122	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—CYP17A1—melanoma	1.69e-05	0.000121	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—SLC5A5—melanoma	1.68e-05	0.000121	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	1.66e-05	0.000119	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism of lipids and lipoproteins—ALB—melanoma	1.64e-05	0.000118	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—GNAQ—melanoma	1.62e-05	0.000117	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—CD44—melanoma	1.62e-05	0.000117	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—PIK3CA—melanoma	1.62e-05	0.000116	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—GNA11—melanoma	1.59e-05	0.000114	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	1.59e-05	0.000114	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—melanoma	1.57e-05	0.000113	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—TP53—melanoma	1.57e-05	0.000112	CbGpPWpGaD
Prasugrel—CYP2B6—Metabolism—PRKCA—melanoma	1.56e-05	0.000112	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—FASN—melanoma	1.56e-05	0.000112	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—CYP1B1—melanoma	1.56e-05	0.000112	CbGpPWpGaD
Prasugrel—CYP2B6—Metabolism—ERCC2—melanoma	1.55e-05	0.000111	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—SLC5A5—melanoma	1.53e-05	0.00011	CbGpPWpGaD
Prasugrel—ALB—Metabolism of lipids and lipoproteins—PTEN—melanoma	1.53e-05	0.00011	CbGpPWpGaD
Prasugrel—ALB—Hemostasis—VEGFA—melanoma	1.52e-05	0.000109	CbGpPWpGaD
Prasugrel—ALB—Hemostasis—NRAS—melanoma	1.5e-05	0.000108	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—HRAS—melanoma	1.5e-05	0.000108	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—GNAQ—melanoma	1.48e-05	0.000106	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—CD44—melanoma	1.48e-05	0.000106	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—PLA2G6—melanoma	1.47e-05	0.000105	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	1.45e-05	0.000104	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—melanoma	1.44e-05	0.000103	CbGpPWpGaD
Prasugrel—ALB—Hemostasis—MAPK3—melanoma	1.44e-05	0.000103	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—IL6—melanoma	1.43e-05	0.000103	CbGpPWpGaD
Prasugrel—ALB—Metabolism—ABCB1—melanoma	1.43e-05	0.000103	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—CYP1B1—melanoma	1.42e-05	0.000102	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—melanoma	1.37e-05	9.86e-05	CbGpPWpGaD
Prasugrel—ALB—Hemostasis—MAPK1—melanoma	1.37e-05	9.81e-05	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—AKT1—melanoma	1.32e-05	9.5e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—VCAN—melanoma	1.32e-05	9.46e-05	CbGpPWpGaD
Prasugrel—ALB—Metabolism—PRKCA—melanoma	1.31e-05	9.43e-05	CbGpPWpGaD
Prasugrel—ALB—Metabolism—ERCC2—melanoma	1.3e-05	9.36e-05	CbGpPWpGaD
Prasugrel—ALB—Hemostasis—KRAS—melanoma	1.29e-05	9.27e-05	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—ABCB1—melanoma	1.28e-05	9.2e-05	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—melanoma	1.25e-05	8.99e-05	CbGpPWpGaD
Prasugrel—CYP2B6—Metabolism—PIK3CG—melanoma	1.22e-05	8.78e-05	CbGpPWpGaD
Prasugrel—ALB—Hemostasis—PIK3CA—melanoma	1.19e-05	8.51e-05	CbGpPWpGaD
Prasugrel—CYP2B6—Metabolism—PPARG—melanoma	1.18e-05	8.47e-05	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—PRKCA—melanoma	1.18e-05	8.47e-05	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—ERCC2—melanoma	1.17e-05	8.4e-05	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—ABCB1—melanoma	1.17e-05	8.39e-05	CbGpPWpGaD
Prasugrel—ALB—Hemostasis—TP53—melanoma	1.15e-05	8.24e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—CYP17A1—melanoma	1.11e-05	7.98e-05	CbGpPWpGaD
Prasugrel—ALB—Hemostasis—HRAS—melanoma	1.1e-05	7.88e-05	CbGpPWpGaD
Prasugrel—ALB—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	1.08e-05	7.75e-05	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—PRKCA—melanoma	1.08e-05	7.72e-05	CbGpPWpGaD
Prasugrel—CYP2B6—Metabolism—PIK3CD—melanoma	1.07e-05	7.72e-05	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—ERCC2—melanoma	1.07e-05	7.66e-05	CbGpPWpGaD
Prasugrel—CYP2B6—Metabolism—ALB—melanoma	1.06e-05	7.62e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—GNA11—melanoma	1.05e-05	7.54e-05	CbGpPWpGaD
Prasugrel—ALB—Metabolism—PIK3CG—melanoma	1.03e-05	7.39e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—FASN—melanoma	1.03e-05	7.38e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—SLC5A5—melanoma	1.01e-05	7.26e-05	CbGpPWpGaD
Prasugrel—ALB—Metabolism—PPARG—melanoma	9.93e-06	7.13e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—CD44—melanoma	9.76e-06	7.01e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—GNAQ—melanoma	9.76e-06	7.01e-05	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	9.69e-06	6.96e-05	CbGpPWpGaD
Prasugrel—ALB—Hemostasis—AKT1—melanoma	9.68e-06	6.95e-05	CbGpPWpGaD
Prasugrel—CYP2B6—Metabolism—PIK3CB—melanoma	9.37e-06	6.73e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—CYP1B1—melanoma	9.36e-06	6.72e-05	CbGpPWpGaD
Prasugrel—CYP2B6—Metabolism—PTGS2—melanoma	9.28e-06	6.66e-05	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—PIK3CG—melanoma	9.24e-06	6.63e-05	CbGpPWpGaD
Prasugrel—ALB—Metabolism—PIK3CD—melanoma	9.05e-06	6.5e-05	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—PPARG—melanoma	8.92e-06	6.4e-05	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	8.83e-06	6.34e-05	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—PIK3CG—melanoma	8.42e-06	6.05e-05	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—PPARG—melanoma	8.13e-06	5.84e-05	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—PIK3CD—melanoma	8.12e-06	5.83e-05	CbGpPWpGaD
Prasugrel—CYP2B6—Metabolism—PTEN—melanoma	8.09e-06	5.81e-05	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—ALB—melanoma	8.02e-06	5.76e-05	CbGpPWpGaD
Prasugrel—ALB—Metabolism—PIK3CB—melanoma	7.88e-06	5.66e-05	CbGpPWpGaD
Prasugrel—ALB—Metabolism—PTGS2—melanoma	7.81e-06	5.61e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—ABCB1—melanoma	7.71e-06	5.53e-05	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—PIK3CD—melanoma	7.4e-06	5.32e-05	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—ALB—melanoma	7.31e-06	5.25e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—PRKCA—melanoma	7.09e-06	5.09e-05	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—PIK3CB—melanoma	7.08e-06	5.08e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—ERCC2—melanoma	7.03e-06	5.05e-05	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—PTGS2—melanoma	7.01e-06	5.04e-05	CbGpPWpGaD
Prasugrel—ALB—Metabolism—PTEN—melanoma	6.81e-06	4.89e-05	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—PIK3CB—melanoma	6.45e-06	4.63e-05	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—PTGS2—melanoma	6.39e-06	4.59e-05	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—PTEN—melanoma	6.12e-06	4.39e-05	CbGpPWpGaD
Prasugrel—CYP2B6—Metabolism—PIK3CA—melanoma	5.71e-06	4.1e-05	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—PTEN—melanoma	5.58e-06	4e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—PIK3CG—melanoma	5.55e-06	3.99e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—PPARG—melanoma	5.36e-06	3.85e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—PIK3CD—melanoma	4.88e-06	3.51e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—ALB—melanoma	4.82e-06	3.46e-05	CbGpPWpGaD
Prasugrel—ALB—Metabolism—PIK3CA—melanoma	4.81e-06	3.45e-05	CbGpPWpGaD
Prasugrel—CYP2B6—Metabolism—AKT1—melanoma	4.66e-06	3.35e-05	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—PIK3CA—melanoma	4.31e-06	3.1e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—PIK3CB—melanoma	4.26e-06	3.06e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—PTGS2—melanoma	4.22e-06	3.03e-05	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—PIK3CA—melanoma	3.93e-06	2.83e-05	CbGpPWpGaD
Prasugrel—ALB—Metabolism—AKT1—melanoma	3.93e-06	2.82e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—PTEN—melanoma	3.68e-06	2.64e-05	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—AKT1—melanoma	3.52e-06	2.53e-05	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—AKT1—melanoma	3.21e-06	2.31e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—PIK3CA—melanoma	2.59e-06	1.86e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—AKT1—melanoma	2.12e-06	1.52e-05	CbGpPWpGaD
